Skip to main content

Table 2 Hepatic FA compositions at the end of week 26

From: A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet

Ingredient (ng/mg liver) Control chow CDAA-HF-T(+) CDAA-HF-T(−)
C14:0 120 ± 21 1131 ± 192 a 1021 ± 140 a
C16:0 5423 ± 715 27,503 ± 4477 a 30,389 ± 5932 a
C16:1n-7 933 ± 268 4856 ± 1258 a 4165 ± 587 a
C18:0 1984 ± 417 3671 ± 291 a 4479 ± 1021 a
C18:1n-7 830 ± 207 10,380 ± 1441 a 4237 ± 414 a
C18:1n-7 t 16 ± 5 2246 ± 315 a 96 ± 15 a, +
C18:1n-9 4860 ± 898 66,045 ± 12,407 a 83,732 ± 19,926 a
C18:1n-9 t 13 ± 7 1647 ± 156 a 155 ± 44 +
C18:2n-6 7692 ± 1247 35,212 ± 1832 a 33,790 ± 8871 a
C18:2n-6tt N.D. 901 ± 63 22 ± 7
C18:3n-3 177 ± 55 154 ± 20 124 ± 40
C18:3n-6 50 ± 32 1393 ± 157 a 2517 ± 73 a, +
C20:0 51 ± 22 169 ± 16 a 224 ± 51 a
C20:2n-6 67 ± 11 433 ± 56 a 354 ± 52 a
C20:3n-6 443 ± 62 1404 ± 89 a 2158 ± 470 a, +
C20:4n-6 2889 ± 434 8668 ± 775 a 12,602 ± 3034 a, +
C20:5n-3 400 ± 91 11 ± 1 a 27 ± 13 a
C22:5n-3 148 ± 26 178 ± 17 219 ± 47 a
C22:6n-3 8754 ± 15 2930 ± 476 a 4184 ± 1178 a
Total 34,850 ± 4687 168,925 ± 20,918 a 184,484 ± 41,347 a
  1. Values are presented as the mean ± SD (n = 4).
  2. Significantly different from the values of acontrol chow or +CDAA-HF-T(+) groups.
  3. N.D. Not detected.
\